announcement?, page-80

Two things that will probably be lost out in the noise of todays announcement...

"... supply Hikma a minimum volume of 175MM units per year following a rapid high-volume ramp up period"

I hope the period of rapid high volume ramp up is not over 18 months. I twould be nice to start banking full wack revenue some time in 2015

But here is the real thing of interest and optimism for me. The Unifill Nexus. It is a syringe barrel with no passive safety. I am assuming the luer lock connection can mean a need can be attached like the Unifill Select...but we are selling prefilled syringe barrels with a luer lock connection.

But it appears our largest contract to date is in part for a device that doesnt use our bespoked passive safety needle retraction.

We supply a barrel and plunger for a prefilled syringe that is use for deliverying drugs into IV drips/lines etc.

So the positive I take from that is we are able to make these things cheap enough that a generic manufacturer can use what appears to be simply a barrel and plunger with no needle retraction.

Will be interesting to see the break up of drugs that find themselves into the traditional Unifill vs the Nexus